Bumrungrad International Hospital
Neuroblastoma treatment cost in Thailand typically includes essential diagnostics like a consultation with a pediatrician ranging from $100 / ฿3,400 to $100 / ฿3,400. Primary interventions such as complex treatment of neuroblastoma often run $45,000 / ฿1,530,000 to $65,000 / ฿2,210,000. Total expenses depend on the cancer stage, clinic tier, and specific therapy protocols. Patients often save 60-80% compared to the US. Top medical destinations include Bangkok and Chiang Mai.
Typical Neuroblastoma Treatment Costs in Thailand
Bookimed Expert Insight: For complex pediatric oncology cases, choosing JCI-accredited facilities ensures international safety standards. Bumrungrad International Hospital is a top-10 global center treating over 500,000 international patients annually. Families seeking specialized diagnostics benefit from doctors like Nichakorn Seehirunwong, who focuses on pediatric oncology. Multidisciplinary teams in Bangkok coordinate advanced surgeries and targeted therapies efficiently within high-tech private centers.
| Thailand | Turkey | Austria | |
| Complex treatment of neuroblastoma | from $45,000 / ฿1,530,000 | from $28,000 / ฿952,000 | from $180,000 / ฿6,120,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Neuroblastoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Neuroblastoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Neuroblastoma treatment journey.
Dr. Nichakorn Seehirunwong is a skilled radiologist specializing in interpreting medical imaging tests for accurate Neuroblastoma diagnosis at Intrarat Hospital.
Dr. Peerapong Montriwiwatchai is an Assistant Professor of Neurosurgery at Bumrungrad International Hospital. He focuses on complex spine surgery and neurological interventions. Dr. Montriwiwatchai completed a fellowship in neurological surgery at Temple University Hospital in Philadelphia. He treats patients at a facility ranked among the top 10 best hospitals globally.
Leading JCI-accredited hospitals in Thailand provide comprehensive neuroblastoma care using multidisciplinary pediatric oncology teams. Facilities like Bumrungrad International and Samitivej International Children's Hospital offer advanced bone marrow transplants. They also provide targeted therapies and complex surgical interventions for high-risk pediatric cases.
Bookimed Expert Insight: While many private hospitals offer oncology, Bumrungrad stands out with over 1,300 doctors across 70 departments. Our data shows this scale is vital for neuroblastoma. This rare cancer requires immediate cooperation between pediatric surgeons and radiologists like Dr. Nichakorn Seehirunwong. Large centers manage these multidisciplinary needs more efficiently than smaller facilities.
Patient Consensus: Parents emphasize choosing a hospital based on its experience with rare solid tumors specifically. They note that having pathology and staging capabilities in-house is critical for accurate risk classification.
Neuroblastoma treatment in Thailand centers on multimodal protocols at JCI-accredited Bangkok hospitals. Options include surgical resection, topotecan-based induction chemotherapy, and radiation therapy. High-risk cases utilize stem cell rescue and advanced CAR NK cell therapy. Specialized pediatric oncology teams manage complex diagnostics, including MIBG-scintigraphy and bone marrow biopsies.
Bookimed Expert Insight: Thailand’s oncology landscape is highly centralized. Bumrungrad International Hospital manages over 1 million patients annually with specialized pediatric teams. While 150+ Thai clinics exist, neuroblastoma expertise is concentrated in Bangkok. Intrarat Hospital utilizes radiologists like Dr. Nichakorn Seehirunwong for MIBG-scintigraphy interpretation. Patients should choose centers with dedicated pediatric ICUs for post-surgical recovery.
Patient Consensus: Families emphasize that pediatric oncology expertise is essential before starting treatment. They recommend confirming the hospital’s ability to coordinate pathology, imaging, and blood product support in one location.
Thai pediatric oncologists treat neuroblastoma using international protocols and advanced therapies. Many doctors hold certifications from the Thai Pediatric Oncology Group. Specialized centers prioritize multi-modality approaches. These include surgery, systemic therapy, and precise radiotherapy. Facilities like Bumrungrad International Hospital maintain JCI accreditation for safety.
Bookimed Expert Insight: Thailand ranks 7th globally on Bookimed for medical travel requests. High-volume centers like Bumrungrad International Hospital serve over 1 million patients annually. Half of these patients are international. This massive volume ensures pediatric teams see rare cases frequently. Such experience often matches or exceeds regional western centers.
Neuroblastoma treatment in Thailand typically spans 15 to 18 months for high-risk cases. Thai hospitals follow Pediatric Oncology Group protocols. These combine chemotherapy, surgery, and stem cell transplants. Low-risk cases may conclude in just a few months through surgery or limited chemo cycles.
Bookimed Expert Insight: While total treatment lasts over 12 months, patient volume at centers like Bumrungrad International suggests many families use Thailand for specific intensive phases. You can arrange surgery or radiation in Bangkok to benefit from advanced technology before returning home for maintenance. This approach optimizes time spent abroad without compromising the biological protocol duration.
Patient Consensus: Parents emphasize that the actual time in the country often depends on blood count recovery between cycles. Delays for pathology or infection recovery are common and can extend the planned stay by several weeks.
Thailand provides advanced neuroblastoma treatments including targeted therapies and CAR NK cell therapy. Major centers in Bangkok use JCI-accredited protocols for high-risk cases. These facilities utilize MIBG-scintigraphy and molecular diagnostics to guide personalized immunotherapy and pediatric oncology regimens.
Bookimed Expert Insight: While Thailand is a top-10 global medical destination, pediatric oncology is highly specialized. Data shows leading centers like Bumrungrad hospital focus on 70+ departments with 1,300 doctors. This concentration of specialists helps coordinate the complex ICU backup and transplant support required for high-risk neuroblastoma.
Patient Consensus: Patients emphasize the need to verify drug approval for anti-GD2 immunotherapy directly with the hospital. They note that having pediatric-specific oncology subspecialists is more important than general hospital rankings.
Thailand reports a 5-year overall survival rate of 81.6% for neuroblastoma at specialized centers. High-risk survival rates range from 45.1% to 52.5% using stem cell rescue. Lower-risk cases typically exceed 95% survival globally. Thai facilities like Bumrungrad International Hospital maintain JCI accreditation for pediatric oncology care.
Bookimed Expert Insight: Thai oncology centers like Bumrungrad International serve 500,000+ international patients yearly. Clinical data shows high-risk treatments may cost approximately $45,000 to $65,000. Choosing a center with specialized pediatric imaging experts, like Dr. Nichakorn Seehirunwong, ensures precise staging. Staging accuracy is vital because it determines if a child needs intensive transplant protocols.
Patient Consensus: Parents find that confirming the risk group early is crucial for setting expectations. They note that hospital stays are long because treatment involves multiple phases like chemo and surgery.